Meet uBriGene at ISSCR 2026: Advancing iPSC Reprogramming with circRNA-LNP Technology

uBriGene Showcases uVivo™ LVV—An IND-Ready In Vivo CAR-T Platform—at ASGCT 2026 Annual Meeting in Boston

uBriGene to Present circRNA-LNP and Lentiviral Manufacturing Innovations at ISCT 2026 in Dublin

uBriGene to Drive Innovation in Cell & Gene Therapy at Advanced Therapies Week 2026 in San Diego

Where Science Meets Strategy: uBriGene Engages Global Leaders at JPM Healthcare Conference 2026

uBriGene to Present High-Yield cGMP Lentiviral Vector Manufacturing Process at the 67th ASH Annual Meeting 2025

uBriGene Biosciences to Showcase End-to-End TIL Manufacturing Innovation at the 7th TIL Therapies Summit in Boston, MA

Meet uBriGene in Philadelphia: Driving the Future of Cell and Gene Therapy at The Advanced Therapies Congress 2025

From LVV Turbo to CAR-TCR Solutions: uBriGene to Showcase Innovation at CAR-TCR Summit 2025 in Boston

Novel sgRNA In Vitro Transcription (IVT) Technology Enhances Gene Editing Efficiency to Debut at the 7th Annual Allogeneic Cell Therapies Summit